This extensive coverage does not extend universally across all types of GLP 1 agonists
CJC-1295 + ipamorelin boost growth hormone to support lean tissue during the deficit
Important considerations before combining these medications include: Absolute contraindications : The combination should be avoided in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, during or within 14 days of MAOI use, personal/family history of MTC or MEN2, pregnancy, breastfeeding, or severe gastrointestinal disease Cardiovascular risk assessment : Phentermine increases heart rate and blood pressure, which requires careful monitoring with baseline and follow-up measurements of vital signs and possibly EKG if cardiac history exists Gastrointestinal tolerability : Tirzepatide commonly causes nausea, vomiting, and diarrhea, which may be compounded by phentermine's effects Medication interactions : Tirzepatide may reduce the effectiveness of oral contraceptives during initiation and dose escalation
Patients with well-managed hypothyroidism on stable levothyroxine replacement can generally proceed with GLP-1 therapy if clinically indicated
Our personalized programs at TrimRx are built on the belief that medication is a tool to be used alongside professional guidance and support